A phase I study of rhuMAb beta7 in moderate to severe Ulcerative Colitis (UC)

Authors
Category Primary study
JournalGastroenterology
Year 2011
This article has no abstract
Epistemonikos ID: 400481698d6f323a84082d6cf6f02157ba4b2209
First added on: Feb 04, 2025